文献速递免疫规划卫生政策与健康促进慢病防控与筛查

不让任何人掉队:作为免疫议程2030的一部分,在未来十年定义并实施疫苗接种的综合全生命周期方法

Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030.
PubMed 文献 · Vaccine · 2022-12-08

免疫议程2030战略优先事项4旨在确保所有人终身受益于推荐免疫并与基本卫生服务整合。本文综述四个重点领域的证据、差距与策略,指出第二年和之后免疫规划需持续加强,并列举2021年MCV2全球覆盖71% vs MCV1 81%、人乳头瘤病毒疫苗全球覆盖仅12%、约65%国家推荐老年人流感疫苗、仅25%推荐老年人肺炎球菌疫苗等缺口。

要点

  • 免疫议程2030战略优先事项4要求免疫规划与所有卫生规划协调合作,实现全生命周期整合。
  • 2021年MCV2全球覆盖71% vs MCV1 81%,人乳头瘤病毒疫苗全球覆盖仅12%。
  • 约65%国家推荐老年人流感疫苗,仅25%推荐老年人肺炎球菌疫苗。

核心结论

  • 实现全生命周期疫苗接种需针对四个重点领域识别需求,如根据当地情况定制策略、开展研究与倡导以动员资源和建立政治意愿。
  • 在COVID-19时期,为全生命周期疫苗接种整合方法争取足够财政支持和需求既是挑战也是机遇。

研究设计与样本

  • 本文综述四个重点领域的证据、差距和策略:生成老年人群疾病负担和潜在疫苗影响的证据;建立意识并推动早期儿童之后的政策;建立贯穿全生命周期的整合交付方法;识别错失接种机会、实施补种策略并监测全生命周期接种。

主要发现

  • 2021年,在出生后第二年接种的含麻疹成分疫苗第二剂(MCV2)全球覆盖率为71%,而MCV1为81%。
  • 60%的国家已将人乳头瘤病毒疫苗纳入接种程序,但2021年全球覆盖率仅为12%。
  • 约65%的国家推荐老年人、高危成人和孕妇接种流感疫苗,仅25%的国家推荐老年人接种肺炎球菌疫苗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Strategic Priority 4 (SP4) of the Immunization Agenda 2030 aims to ensure that all people benefit from recommended immunizations throughout the life-course, integrated with essential health services. Therefore, it is necessary for immunization programs to have coordination and collaboration across all health programs. Although there has been progress, immunization platforms in the second year of life and beyond need continued strengthening, including booster doses and catch-up vaccination, for all ages, and recommended vaccines for older age groups. We note gaps in current vaccination programs policies and achieved coverage, in the second year of life and beyond. In 2021, the second dose of measles-containing vaccine (MCV2), given in the second year of life, achieved 71% global coverage vs 81% for MCV1. For adolescents, 60% of all countries have adopted human papillomavirus vaccines in their vaccination schedule with a global coverage rate of only 12 percent in 2021. Approximately 65% of the countries recommend influenza vaccines for older adults, high-risk adults and pregnant women, and only 25% recommended pneumococcal vaccines for older adults. To achieve an integrated life course approach to vaccination, we reviewed the evidence, gaps, and strategies in four focus areas: generating evidence for disease burden and potential vaccine impact in older age groups; building awareness and shifting policy beyond early childhood; building integrated delivery approaches throughout the life course; and identifying missed opportunities for vaccination, implementing catch-up strategies, and monitoring vaccination throughout the life course. We identified needs, such as tailoring strategies to the local context, conducting research and advocacy to mobilize resources and build political will. Mustering sufficient financial support and demand for an integrated life course approach to vaccination, particularly in times of COVID-19, is both a challenge and an opportunity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wallace AS, Ryman TK, Privor-Dumm L, et al. Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030. Vaccine. 2022. PMID: 36503859. doi:10.1016/j.vaccine.2022.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。